Application of Polymer Materials in Targeting Glioma


Дәйексөз келтіру

Толық мәтін

Аннотация

Glioma is a serious life-threatening disease, and traditional treatments have little effect. In recent decades, polymer materials have been developed for the treatment of glioma as a new research area. The ability to target reactive polymeric carriers is important for treating glioma. Polymer materials have good designability and expansibility. They respond to different stimuli, leading to a change in the macroscopic properties of materials. Sensitive polymer carriers respond to biological stimuli (pH, oxidative stress, enzyme, temperature, ions and nucleic acids) and the tumour microenvironment. They can be used as intelligent polymer carriers to transport chemotherapy and imaging drugs for glioma treatment. The ability of these polymer carriers to control the release of molecules at tumour-specific sites has aroused great interest. This review summarizes current research on sensitive polymer-carriers for glioma treatment over the past decade, focusing on their clinical application prospects. Finally, future applications of polymer carriers in nanomedicine are reviewed.

Авторлар туралы

Jia Guo

School of Basic Medical Sciences, Yunnan University of Chinese Medicine

Email: info@benthamscience.net

Zheng Yao

School of Basic Medical Sciences, Yunnan University of Chinese Medicine

Email: info@benthamscience.net

Feiyu Zhang

School of Basic Medical Sciences, Yunnan University of Chinese Medicine

Хат алмасуға жауапты Автор.
Email: info@benthamscience.net

Junzi Wu

School of Basic Medical Sciences, Yunnan University of Chinese Medicine

Хат алмасуға жауапты Автор.
Email: info@benthamscience.net

Әдебиет тізімі

  1. Jiang, Y.; Uhrbom, L. On the origin of glioma. Ups. J. Med. Sci., 2012, 117(2), 113-121. doi: 10.3109/03009734.2012.658976 PMID: 22348397
  2. Bleeker, F.E.; Molenaar, R.J.; Leenstra, S. Recent advances in the molecular understanding of glioblastoma. J. Neurooncol., 2012, 108(1), 11-27. doi: 10.1007/s11060-011-0793-0 PMID: 22270850
  3. Lacroix, M.; Abi-Said, D.; Fourney, D.R.; Gokaslan, Z.L.; Shi, W.; DeMonte, F.; Lang, F.F.; McCutcheon, I.E.; Hassenbusch, S.J.; Hol-land, E.; Hess, K.; Michael, C.; Miller, D.; Sawaya, R. A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, ex-tent of resection, and survival. J. Neurosurg., 2001, 95(2), 190-198. doi: 10.3171/jns.2001.95.2.0190 PMID: 11780887
  4. Stewart, L.A. Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 random-ised trials. Lancet, 2002, 359(9311), 1011-1018. doi: 10.1016/S0140-6736(02)08091-1 PMID: 11937180
  5. Siegel, R.A. Stimuli sensitive polymers and self regulated drug delivery systems: A very partial review. J. Control. Release, 2014, 190, 337-351. doi: 10.1016/j.jconrel.2014.06.035 PMID: 24984012
  6. Yan, L.; Li, X. Biodegradable stimuli-responsive polymeric micelles for treatment of malignancy. Curr. Pharm. Biotechnol., 2016, 17(3), 227-236. doi: 10.2174/138920101703160206142821 PMID: 26873075
  7. Lu, Y.; Sun, W.; Gu, Z. Stimuli-responsive nanomaterials for therapeutic protein delivery. J. Control. Release, 2014, 194, 1-19. doi: 10.1016/j.jconrel.2014.08.015 PMID: 25151983
  8. Farokhzad, O.C.; Langer, R. Impact of nanotechnology on drug delivery. ACS Nano, 2009, 3(1), 16-20. doi: 10.1021/nn900002m PMID: 19206243
  9. Allen, T.M.; Cullis, P.R. Drug delivery systems: Entering the mainstream. Science, 2004, 303(5665), 1818-1822. doi: 10.1126/science.1095833 PMID: 15031496
  10. Peer, D.; Karp, J.M.; Hong, S.; Farokhzad, O.C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol., 2007, 2(12), 751-760. doi: 10.1038/nnano.2007.387 PMID: 18654426
  11. Davis, M.E.; Chen, Z.; Shin, D.M. Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat. Rev. Drug Discov., 2008, 7(9), 771-782. doi: 10.1038/nrd2614 PMID: 18758474
  12. Gutkin, A.; Cohen, Z.R.; Peer, D. Harnessing nanomedicine for therapeutic intervention in glioblastoma. Expert Opin. Drug Deliv., 2016, 13(11), 1573-1582. doi: 10.1080/17425247.2016.1200557 PMID: 27292970
  13. Mangraviti, A.; Gullotti, D.; Tyler, B.; Brem, H. Nanobiotechnology-based delivery strategies: New frontiers in brain tumor targeted thera-pies. J. Control. Release, 2016, 240, 443-453. doi: 10.1016/j.jconrel.2016.03.031 PMID: 27016141
  14. Meng, J.; Agrahari, V.; Youm, I. Advances in targeted drug delivery approaches for the central nervous system tumors: The Inspiration of nanobiotechnology. J. Neuroimmune Pharmacol., 2017, 12(1), 84-98. doi: 10.1007/s11481-016-9698-1 PMID: 27449494
  15. Yasaswi, P.S.; Shetty, K.; Yadav, K.S. Temozolomide nano enabled medicine: Promises made by the nanocarriers in glioblastoma therapy. J. Control. Release, 2021, 336, 549-571. doi: 10.1016/j.jconrel.2021.07.003 PMID: 34229001
  16. Duncan, R. Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer, 2006, 6(9), 688-701. doi: 10.1038/nrc1958 PMID: 16900224
  17. Hubbell, J.A.; Langer, R. Translating materials design to the clinic. Nat. Mater., 2013, 12(11), 963-966. doi: 10.1038/nmat3788 PMID: 24150414
  18. Kataoka, K.; Harada, A.; Nagasaki, Y. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv. Drug Deliv. Rev., 2001, 47(1), 113-131. doi: 10.1016/S0169-409X(00)00124-1 PMID: 11251249
  19. Nishiyama, N.; Kataoka, K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol. Ther., 2006, 112(3), 630-648. doi: 10.1016/j.pharmthera.2006.05.006 PMID: 16815554
  20. Bae, Y.; Kataoka, K. Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. Adv. Drug Deliv. Rev., 2009, 61(10), 768-784. doi: 10.1016/j.addr.2009.04.016 PMID: 19422866
  21. Matsumura, Y.; Kataoka, K. Preclinical and clinical studies of anticancer agent-incorporating polymer micelles. Cancer Sci., 2009, 100(4), 572-579. doi: 10.1111/j.1349-7006.2009.01103.x PMID: 19462526
  22. Miyata, K.; Nishiyama, N.; Kataoka, K. Rational design of smart supramolecular assemblies for gene delivery: Chemical challenges in the creation of artificial viruses. Chem. Soc. Rev., 2012, 41(7), 2562-2574. doi: 10.1039/C1CS15258K PMID: 22105545
  23. Cabral, H.; Kataoka, K. Progress of drug-loaded polymeric micelles into clinical studies. J. Control. Release, 2014, 190, 465-476. doi: 10.1016/j.jconrel.2014.06.042 PMID: 24993430
  24. Cabral, H.; Matsumoto, Y.; Mizuno, K.; Chen, Q.; Murakami, M.; Kimura, M.; Terada, Y.; Kano, M.R.; Miyazono, K.; Uesaka, M.; Nishiyama, N.; Kataoka, K. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat. Nanotechnol., 2011, 6(12), 815-823. doi: 10.1038/nnano.2011.166 PMID: 22020122
  25. Raveendran, R.; Bhuvaneshwar, G.S.; Sharma, C.P. Hemocompatible curcumin-dextran micelles as pH sensitive pro-drugs for enhanced therapeutic efficacy in cancer cells. Carbohydr. Polym., 2016, 137, 497-507. doi: 10.1016/j.carbpol.2015.11.017 PMID: 26686156
  26. Sun, P.; Wu, Z.; Xiao, Y.; Wu, H.; Di, Q.; Zhao, X.; Quan, J.; Tang, H.; Wang, Q.; Chen, W. TfR-T12 short peptide and pH sensitive cell transmembrane peptide modified nano-composite micelles for glioma treatment via remodeling tumor microenvironment. Nanomedicine, 2022, 41, 102516. doi: 10.1016/j.nano.2022.102516 PMID: 35131469
  27. Yin, Y.; Wang, J.; Yang, M.; Du, R.; Pontrelli, G.; McGinty, S.; Wang, G.; Yin, T.; Wang, Y. Penetration of the blood-brain barrier and the anti-tumour effect of a novel PLGA-lysoGM1/DOX micelle drug delivery system. Nanoscale, 2020, 12(5), 2946-2960. doi: 10.1039/C9NR08741A PMID: 31994576
  28. Li, J.; Du, Y.; Jiang, Z.; Tian, Y.; Qiu, N.; Wang, Y. lqbal, M.Z.; Hu, M.; Zou, R.; Luo, L.; Du, S.; Tian, J.; Wu, A. Y1 receptor ligand-based nanomicelle as a novel nanoprobe for glioma-targeted imaging and therapy. Nanoscale, 2018, 10(13), 5845-5851. doi: 10.1039/C8NR00148K PMID: 29542782
  29. Shamul, J.G.; Shah, S.R.; Kim, J.; Schiapparelli, P.; Vazquez-Ramos, C.A.; Lee, B.J.; Patel, K.K.; Shin, A.; Quinones-Hinojosa, A.; Green, J.J. Verteporfin-loaded anisotropic poly(beta-amino ester)-based micelles demonstrate brain cancer-selective cytotoxicity and enhanced pharmacokinetics. Int. J. Nanomedicine, 2019, 14, 10047-10060. doi: 10.2147/IJN.S231167 PMID: 31920302
  30. Wang, G.; Wang, J.J.; Chen, X.L.; Du, L.; Li, F. Quercetin-loaded freeze-dried nanomicelles: Improving absorption and anti-glioma effi-ciency in vitro and in vivo. J. Control. Release, 2016, 235, 276-290. doi: 10.1016/j.jconrel.2016.05.045 PMID: 27242199
  31. Groult, H.; García-Álvarez, I.; Romero-Ramírez, L.; Nieto-Sampedro, M.; Herranz, F.; Fernández-Mayoralas, A.; Ruiz-Cabello, J. Micellar iron oxide nanoparticles coated with anti-tumor glycosides. Nanomaterials, 2018, 8(8), 567. doi: 10.3390/nano8080567 PMID: 30044386
  32. Singleton, W.G.; Collins, A.M.; Bienemann, A.S.; Killick-Cole, C.L.; Haynes, H.R.; Asby, D.J.; Butts, C.P.; Wyatt, M.J.; Barua, N.U.; Gill, S.S. Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model. Int. J. Nanomedicine, 2017, 12, 1385-1399. doi: 10.2147/IJN.S125300 PMID: 28260886
  33. Fan, Q.; Liu, Y.; Cui, G.; Zhong, Z.; Deng, C. Brain delivery of Plk1 inhibitor via chimaeric polypeptide polymersomes for safe and su-perb treatment of orthotopic glioblastoma. J. Control. Release, 2021, 329, 1139-1149. doi: 10.1016/j.jconrel.2020.10.043 PMID: 33131697
  34. Tian, C.; Asghar, S.; Xu, Y.; Chen, Z.; Zhang, M.; Huang, L.; Ye, J.; Ping, Q.; Xiao, Y. The effect of the molecular weight of hyaluronic acid on the physicochemical characterization of hyaluronic acid-curcumin conjugates and in vitro evaluation in glioma cells. Colloids Surf. B Biointerfaces, 2018, 165, 45-55. doi: 10.1016/j.colsurfb.2018.02.016 PMID: 29453085
  35. Tan, J.; Duan, X.; Zhang, F.; Ban, X.; Mao, J.; Cao, M.; Han, S.; Shuai, X.; Shen, J. Theranostic nanomedicine for synergistic chemody-namic therapy and chemotherapy of orthotopic glioma. Adv. Sci., 2020, 7(24), 2003036. doi: 10.1002/advs.202003036 PMID: 33344142
  36. Xu, J.; Yang, X.; Ji, J.; Gao, Y.; Qiu, N.; Xi, Y.; Liu, A.; Zhai, G. RVG-functionalized reduction sensitive micelles for the effective accu-mulation of doxorubicin in brain. J. Nanobiotechnology, 2021, 19(1), 251. doi: 10.1186/s12951-021-00997-z PMID: 34419071
  37. Zhu, Y.; Jiang, Y.; Meng, F.; Deng, C.; Cheng, R.; Zhang, J.; Feijen, J.; Zhong, Z. Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides. J. Control. Release, 2018, 278, 1-8. doi: 10.1016/j.jconrel.2018.03.025 PMID: 29596873
  38. Lu, L.; Zhao, X.; Fu, T.; Li, K.; He, Y.; Luo, Z.; Dai, L.; Zeng, R.; Cai, K. An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy. Biomaterials, 2020, 230, 119666. doi: 10.1016/j.biomaterials.2019.119666 PMID: 31831222
  39. Wang, P.; Yu, N.; Wang, Y.; Sun, H.; Yang, Z.; Zhou, S. Co-delivery of PLK1-specific shRNA and doxorubicin via core-crosslinked pH-sensitive and redox ultra-sensitive micelles for glioma therapy. J. Mater. Chem. B Mater. Biol. Med., 2018, 6(1), 112-124. doi: 10.1039/C7TB02160G PMID: 32254199
  40. Quader, S.; Liu, X.; Toh, K.; Su, Y.L.; Maity, A.R.; Tao, A.; Paraiso, W.K.D.; Mochida, Y.; Kinoh, H.; Cabral, H.; Kataoka, K. Supramo-lecularly enabled pH-triggered drug action at tumor microenvironment potentiates nanomedicine efficacy against glioblastoma. Biomaterials, 2021, 267, 120463. doi: 10.1016/j.biomaterials.2020.120463 PMID: 33130321
  41. Yang, Y.; Zhang, X.; Wu, S.; Zhang, R.; Zhou, B.; Zhang, X.; Tang, L.; Tian, Y.; Men, K.; Yang, L. Enhanced nose-to-brain delivery of siRNA using hyaluronan-enveloped nanomicelles for glioma therapy. J. Control. Release, 2022, 342, 66-80. doi: 10.1016/j.jconrel.2021.12.034 PMID: 34973309
  42. Kanazawa, T.; Morisaki, K.; Suzuki, S.; Takashima, Y. Prolongation of life in rats with malignant glioma by intranasal siRNA/drug codelivery to the brain with cell-penetrating peptide-modified micelles. Mol. Pharm., 2014, 11(5), 1471-1478. doi: 10.1021/mp400644e PMID: 24708261
  43. Kanazawa, T.; Taki, H.; Okada, H. Nose-to-brain drug delivery system with ligand/cell-penetrating peptide-modified polymeric nano-micelles for intracerebral gliomas. Eur. J. Pharm. Biopharm., 2020, 152, 85-94. doi: 10.1016/j.ejpb.2020.05.001 PMID: 32387702
  44. Akiyoshi, K.; Kobayashi, S.; Shichibe, S.; Mix, D.; Baudys, M.; Wan Kim, S.; Sunamoto, J. Self-assembled hydrogel nanoparticle of cho-lesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin. J. Control. Release, 1998, 54(3), 313-320. doi: 10.1016/S0168-3659(98)00017-0 PMID: 9766251
  45. Mangalathillam, S.; Rejinold, N.S.; Nair, A.; Lakshmanan, V.K.; Nair, S.V.; Jayakumar, R. Curcumin loaded chitin nanogels for skin can-cer treatment via the transdermal route. Nanoscale, 2012, 4(1), 239-250. doi: 10.1039/C1NR11271F PMID: 22080352
  46. Vashist, A.; Kaushik, A.; Vashist, A.; Bala, J.; Nikkhah-Moshaie, R.; Sagar, V.; Nair, M. Nanogels as potential drug nanocarriers for CNS drug delivery. Drug Discov. Today, 2018, 23(7), 1436-1443. doi: 10.1016/j.drudis.2018.05.018 PMID: 29775669
  47. Aderibigbe, B.; Naki, T. Design and efficacy of nanogels formulations for intranasal administration. Molecules, 2018, 23(6), 1241. doi: 10.3390/molecules23061241 PMID: 29789506
  48. Jo, D.H.; Kim, J.H.; Lee, T.G.; Kim, J.H. Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases. Nanomedicine, 2015, 11(7), 1603-1611. doi: 10.1016/j.nano.2015.04.015 PMID: 25989200
  49. Jiang, L.; Zhou, Q.; Mu, K.; Xie, H.; Zhu, Y.; Zhu, W.; Zhao, Y.; Xu, H.; Yang, X. pH/temperature sensitive magnetic nanogels conjugated with Cy5.5-labled lactoferrin for MR and fluorescence imaging of glioma in rats. Biomaterials, 2013, 34(30), 7418-7428. doi: 10.1016/j.biomaterials.2013.05.078 PMID: 23810255
  50. Javed, B.; Zhao, X.; Cui, D.; Curtin, J.; Tian, F. Enhanced anticancer response of curcumin- and piperine-loaded lignin-g-p (NIPAM-co-DMAEMA) gold nanogels against u-251 mg glioblastoma multiforme. Biomedicines, 2021, 9(11), 1516. doi: 10.3390/biomedicines9111516 PMID: 34829745
  51. McCrorie, P.; Mistry, J.; Taresco, V.; Lovato, T.; Fay, M.; Ward, I.; Ritchie, A.A.; Clarke, P.A.; Smith, S.J.; Marlow, M.; Rahman, R. Etoposide and olaparib polymer-coated nanoparticles within a bioadhesive sprayable hydrogel for post-surgical localised delivery to brain tumours. Eur. J. Pharm. Biopharm., 2020, 157, 108-120. doi: 10.1016/j.ejpb.2020.10.005 PMID: 33068736
  52. Ito, S.; Nabetani, T.; Shinoda, Y.; Nagatsuka, Y.; Hirabayashi, Y. Quantitative analysis of a novel glucosylated phospholipid by liquid chromatography-mass spectrometry. Anal. Biochem., 2008, 376(2), 252-257. doi: 10.1016/j.ab.2008.02.007 PMID: 18342611
  53. Liu, W.; Luo, B.; Liang, H.; Zhang, S.; Qin, X.; Liu, X.; Zeng, F.; Wu, Y.; Yang, X. Novel lactoferrin-conjugated amphiphilic poly(aminoethyl ethylene phosphate)/poly(L-lactide) copolymer nanobubbles for tumor-targeting ultrasonic imaging. Int. J. Nanomedicine, 2015, 10, 5805-5817. doi: 10.2147/IJN.S83582 PMID: 26396514
  54. Zhan, J.; Zhong, J.; Ma, S.; Ma, W.; Wang, Y.; Yu, Z.; Cai, Y.; Huang, W. Dual-responsive self-assembly in lysosomes enables cell cycle arrest for locking glioma cell growth. Chem. Commun., 2020, 56(51), 6957-6960. doi: 10.1039/C9CC09983B PMID: 32436508
  55. Singh, S.; Drude, N.; Blank, L.; Desai, P.B.; Königs, H.; Rütten, S.; Langen, K.J.; Möller, M.; Mottaghy, F.M.; Morgenroth, A. Protease responsive nanogels for transcytosis across the blood−brain barrier and intracellular delivery of radiopharmaceuticals to brain tumor cells. Adv. Healthc. Mater., 2021, 10(20), 2100812. doi: 10.1002/adhm.202100812 PMID: 34490744
  56. Lu, Y.J.; Lan, Y.H.; Chuang, C.C.; Lu, W.T.; Chan, L.Y.; Hsu, P.W.; Chen, J.P. Injectable thermo-sensitive chitosan hydrogel containing CPT-11-loaded EGFR-targeted graphene oxide and SLP2 shRNA for localized drug/gene delivery in glioblastoma therapy. Int. J. Mol. Sci., 2020, 21(19), 7111. doi: 10.3390/ijms21197111 PMID: 32993166
  57. Belousov, A.; Titov, S.; Shved, N.; Malykin, G.; Kovalev, V.; Suprunova, I.; Khotimchenko, Y.; Kumeiko, V. Hydrogels based on modi-fied pectins capable of modulating neural cell behavior as prospective biomaterials in glioblastoma treatment. Int. Rev. Neurobiol., 2020, 151, 111-138. doi: 10.1016/bs.irn.2020.03.025 PMID: 32448603
  58. Gao, X.; Li, S.; Ding, F.; Liu, X.; Wu, Y.; Li, J.; Feng, J.; Zhu, X.; Zhang, C. A virus-mimicking nucleic acid nanogel reprograms microglia and macrophages for glioblastoma therapy. Adv. Mater., 2021, 33(9), 2006116. doi: 10.1002/adma.202006116 PMID: 33501743
  59. Rao, S.S.; DeJesus, J.; Short, A.R.; Otero, J.J.; Sarkar, A.; Winter, J.O. Glioblastoma behaviors in three-dimensional collagen-hyaluronan composite hydrogels. ACS Appl. Mater. Interfaces, 2013, 5(19), 9276-9284. doi: 10.1021/am402097j PMID: 24010546
  60. Xiao, T.; He, M.; Xu, F.; Fan, Y.; Jia, B.; Shen, M.; Wang, H.; Shi, X. Macrophage membrane-camouflaged responsive polymer nanogels enable magnetic resonance imaging-guided chemotherapy/chemodynamic therapy of orthotopic glioma. ACS Nano, 2021, 15(12), 20377-20390. doi: 10.1021/acsnano.1c08689 PMID: 34860014
  61. Torchilin, V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov., 2005, 4(2), 145-160. doi: 10.1038/nrd1632 PMID: 15688077
  62. Deshpande, P.P.; Biswas, S.; Torchilin, V.P. Current trends in the use of liposomes for tumor targeting. Nanomedicine, 2013, 8(9), 1509-1528. doi: 10.2217/nnm.13.118 PMID: 23914966
  63. Crommelin, D.J.A.; Storm, G. Liposomes: From the bench to the bed. J. Liposome Res., 2003, 13(1), 33-36. doi: 10.1081/LPR-120017488 PMID: 12725726
  64. Lu, J.; Li, R.; Mu, B.; Peng, Y.; Zhao, Y.; Shi, Y.; Guo, L.; Hai, L.; Wu, Y. Multiple targeted doxorubicin-lonidamine liposomes modified with p-hydroxybenzoic acid and triphenylphosphonium to synergistically treat glioma. Eur. J. Med. Chem., 2022, 230, 114093. doi: 10.1016/j.ejmech.2021.114093 PMID: 35007860
  65. Tao, J.; Fei, W.; Tang, H.; Li, C.; Mu, C.; Zheng, H.; Li, F.; Zhu, Z. Angiopep-2-conjugated "core-shell" hybrid nanovehicles for targeted and pH-Triggered delivery of arsenic trioxide into glioma. Mol. Pharm., 2019, 16(2), 786-797. doi: 10.1021/acs.molpharmaceut.8b01056 PMID: 30620881
  66. Li, M.; Shi, K.; Tang, X.; Wei, J.; Cun, X.; Chen, X.; Yu, Q.; Zhang, Z.; He, Q. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma. Eur. J. Pharm. Sci., 2018, 124, 240-248. doi: 10.1016/j.ejps.2018.07.055 PMID: 30071282
  67. Liu, H.; Cai, Y.; Zhang, Y.; Xie, Y.; Qiu, H.; Hua, L.; Liu, X.; Li, Y.; Lu, J.; Zhang, L.; Yu, R. Development of a hypoxic radiosensitizer-prodrug liposome delivery DNA repair inhibitor dbait combination with radiotherapy for glioma therapy. Adv. Healthc. Mater., 2017, 6(12), 1601377. doi: 10.1002/adhm.201601377 PMID: 28371526
  68. Lu, F.; Pang, Z.; Zhao, J.; Jin, K.; Li, H.; Pang, Q.; Zhang, L.; Pang, Z. Angiopep-2-conjugated poly(ethylene glycol)-co-poly(ϵ-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats. Int. J. Nanomedicine, 2017, 12, 2117-2127. doi: 10.2147/IJN.S123422 PMID: 28356732
  69. Jiao, Z.; Li, Y.; Pang, H.; Zheng, Y.; Zhao, Y. Pep-1 peptide-functionalized liposome to enhance the anticancer efficacy of cilengitide in glioma treatment. Colloids Surf. B Biointerfaces, 2017, 158, 68-75. doi: 10.1016/j.colsurfb.2017.03.058 PMID: 28672205
  70. Yuan, J.; Zeng, C.; Cao, W.; Zhou, X.; Pan, Y.; Xie, Y.; Zhang, Y.; Yang, Q.; Wang, S. Bufalin-loaded PEGylated liposomes: Antitumor efficacy, acute toxicity, and tissue distribution. Nanoscale Res. Lett., 2019, 14(1), 223. doi: 10.1186/s11671-019-3057-0 PMID: 31278603
  71. Joshi, S.; Cooke, J.R.N.; Chan, D.K.W.; Ellis, J.A.; Hossain, S.S.; Singh-Moon, R.P.; Wang, M.; Bigio, I.J.; Bruce, J.N.; Straubinger, R.M. Liposome size and charge optimization for intra-arterial delivery to gliomas. Drug Deliv. Transl. Res., 2016, 6(3), 225-233. doi: 10.1007/s13346-016-0294-y PMID: 27091339
  72. Xue, J.; Zhao, Z.; Zhang, L.; Xue, L.; Shen, S.; Wen, Y.; Wei, Z.; Wang, L.; Kong, L.; Sun, H.; Ping, Q.; Mo, R.; Zhang, C. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat. Nanotechnol., 2017, 12(7), 692-700. doi: 10.1038/nnano.2017.54 PMID: 28650441
  73. Najlah, M.; Jain, M.; Wan, K.W.; Ahmed, W.; Albed Alhnan, M.; Phoenix, D.A.; Taylor, K.M.G.; Elhissi, A. Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells. J. Liposome Res., 2018, 28(1), 74-85. doi: 10.1080/08982104.2016.1259628 PMID: 27834116
  74. Yue, P.; He, L.; Qiu, S.; Li, Y.; Liao, Y.; Li, X.; Xie, D.; Peng, Y. OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma. Mol. Cancer, 2014, 13(1), 191. doi: 10.1186/1476-4598-13-191 PMID: 25128329
  75. Shein, S.A.; Kuznetsov, I.I.; Abakumova, T.O.; Chelushkin, P.S.; Melnikov, P.A.; Korchagina, A.A.; Bychkov, D.A.; Seregina, I.F.; Bol-shov, M.A.; Kabanov, A.V.; Chekhonin, V.P.; Nukolova, N.V. VEGF- and VEGFR2-Targeted liposomes for cisplatin delivery to glioma cells. Mol. Pharm., 2016, 13(11), 3712-3723. doi: 10.1021/acs.molpharmaceut.6b00519 PMID: 27654150
  76. Hu, J.; Wang, J.; Wang, G.; Yao, Z.; Dang, X. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells. Int. J. Mol. Med., 2016, 37(3), 690-702. doi: 10.3892/ijmm.2016.2458 PMID: 26782731
  77. Huang, F.Y.; Lee, T.W.; Chang, C.H.; Chen, L.C.; Hsu, W.H.; Chang, C.W.; Lo, J.M. Evaluation of 188Re-labeled PEGylated nanolipo-some as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model. Int. J. Nanomedicine, 2015, 10, 463-473. doi: 10.2147/IJN.S75955 PMID: 25624760
  78. Wang, X.; Meng, N.; Wang, S.; Zhang, Y.; Lu, L.; Wang, R.; Ruan, H.; Jiang, K.; Wang, H.; Ran, D.; Zhan, C.; Yu, K.; Burgess, D.J.; Lu, W. Non-immunogenic, low-toxicity and effective glioma targeting MTI-31 liposomes. J. Control. Release, 2019, 316, 381-392. doi: 10.1016/j.jconrel.2019.11.005 PMID: 31730912
  79. Alves, A.; Correia-da-Silva, M.; Nunes, C.; Campos, J.; Sousa, E.; Silva, P.; Bousbaa, H.; Rodrigues, F.; Ferreira, D.; Costa, P.; Pinto, M. Discovery of a new xanthone against glioma: synthesis and development of (pro)liposome formulations. Molecules, 2019, 24(3), 409. doi: 10.3390/molecules24030409 PMID: 30678085
  80. Shi, M.; Anantha, M.; Wehbe, M.; Bally, M.B.; Fortin, D.; Roy, L.O.; Charest, G.; Richer, M.; Paquette, B.; Sanche, L. Liposomal formula-tions of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats. J. Nanobi-otechnol., 2018, 16(1), 77. doi: 10.1186/s12951-018-0404-8 PMID: 30290821
  81. Han, Y.; Park, J.H. Convection-enhanced delivery of liposomal drugs for effective treatment of glioblastoma multiforme. Drug Deliv. Transl. Res., 2020, 10(6), 1876-1887. doi: 10.1007/s13346-020-00773-w PMID: 32367425
  82. Saw, P.E.; Kim, S.; Lee, I.; Park, J.; Yu, M.; Lee, J.; Kim, J.I.; Jon, S. Aptide-conjugated liposome targeting tumor-associated fibronectin for glioma therapy. J. Mater. Chem. B Mater. Biol. Med., 2013, 1(37), 4723-4726. doi: 10.1039/c3tb20815j PMID: 32261155
  83. Bredlau, A.L.; Motamarry, A.; Chen, C.; McCrackin, M.A.; Helke, K.; Armeson, K.E.; Bynum, K.; Broome, A.M.; Haemmerich, D. Local-ized delivery of therapeutic doxorubicin dose across the canine blood-brain barrier with hyperthermia and temperature sensitive lipo-somes. Drug Deliv., 2018, 25(1), 973-984. doi: 10.1080/10717544.2018.1461280 PMID: 29688083
  84. Shi, D.; Mi, G.; Shen, Y.; Webster, T.J. Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier. Nanoscale, 2019, 11(32), 15057-15071. doi: 10.1039/C9NR03931G PMID: 31369016
  85. Lin, C.Y.; Li, R.J.; Huang, C.Y.; Wei, K.C.; Chen, P.Y. Controlled release of liposome-encapsulated temozolomide for brain tumour treat-ment by convection-enhanced delivery. J. Drug Target., 2018, 26(4), 325-332. doi: 10.1080/1061186X.2017.1379526 PMID: 28911239
  86. Lu, Y.J. S, A.T.; Chuang, C.C.; Chen, J.P. Liposomal IR-780 as a highly stable nanotheranostic agent for improved photother-mal/photodynamic therapy of brain tumors by convection-enhanced delivery. Cancers, 2021, 13(15), 3690. doi: 10.3390/cancers13153690 PMID: 34359590
  87. Narendra; Mehata, A.K.; Viswanadh, M.K.; Sonkar, R.; Pawde, D.M.; Priya, V.; Singh, M.; Koch, B.; S Muthu, M. Formulation and in vitro evaluation of upconversion nanoparticle-loaded liposomes for brain cancer. Ther. Deliv., 2020, 11(9), 557-571. doi: 10.4155/tde-2020-0070 PMID: 32867624
  88. Andresen, T.; Bruun, J.; Larsen, T.B.; Jølck, R.I.; Eliasen, R.; Holm, R.; Gjetting, T. Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood-brain barrier and glioma cells. Int. J. Nanomedicine, 2015, 10, 5995-6008. doi: 10.2147/IJN.S87334 PMID: 26451106
  89. Wei, X.; Gao, J.; Zhan, C.; Xie, C.; Chai, Z.; Ran, D.; Ying, M.; Zheng, P.; Lu, W. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. J. Control. Release, 2015, 218, 13-21. doi: 10.1016/j.jconrel.2015.09.059 PMID: 26428462
  90. Ying, M.; Shen, Q.; Liu, Y.; Yan, Z.; Wei, X.; Zhan, C.; Gao, J.; Xie, C.; Yao, B.; Lu, W. Stabilized heptapeptide A7R for enhanced multi-functional liposome-based tumor-targeted drug delivery. ACS Appl. Mater. Interfaces, 2016, 8(21), 13232-13241. doi: 10.1021/acsami.6b01300 PMID: 27195531
  91. Ying, M.; Zhan, C.; Wang, S.; Yao, B.; Hu, X.; Song, X.; Zhang, M.; Wei, X.; Xiong, Y.; Lu, W. Liposome-based systemic glioma-targeted drug delivery enabled by all D peptides. ACS Appl. Mater. Interfaces, 2016, 8(44), 29977-29985. doi: 10.1021/acsami.6b10146 PMID: 27797175
  92. Jose, G.; Lu, Y.J.; Hung, J.T.; Yu, A.L.; Chen, J.P. Co-delivery of CPT-11 and panobinostat with anti-GD2 antibody conjugated immu-noliposomes for targeted combination chemotherapy. Cancers, 2020, 12(11), 3211. doi: 10.3390/cancers12113211 PMID: 33142721
  93. Kim, J.S.; Shin, D.H.; Kim, J.S. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells. J. Control. Release, 2018, 269, 245-257. doi: 10.1016/j.jconrel.2017.11.026 PMID: 29162480
  94. Zheng, Z.; Zhang, J.; Jiang, J.; He, Y.; Zhang, W.; Mo, X.; Kang, X.; Xu, Q.; Wang, B.; Huang, Y. Remodeling tumor immune microenvi-ronment (TIME) for glioma therapy using multi-targeting liposomal codelivery. J. Immunother. Cancer, 2020, 8(2), e000207. doi: 10.1136/jitc-2019-000207 PMID: 32817393
  95. Saw, P.E.; Zhang, A.; Nie, Y.; Zhang, L.; Xu, Y.; Xu, X. Tumor-associated fibronectin targeted liposomal nanoplatform for cyclophilin A siRNA Delivery and targeted malignant glioblastoma therapy. Front. Pharmacol., 2018, 9, 1194. doi: 10.3389/fphar.2018.01194 PMID: 30386245
  96. Papachristodoulou, A.; Signorell, R.D.; Werner, B.; Brambilla, D.; Luciani, P.; Cavusoglu, M.; Grandjean, J.; Silginer, M.; Rudin, M.; Mar-tin, E.; Weller, M.; Roth, P.; Leroux, J.C. Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of thera-peutic liposomes. J. Control. Release, 2019, 295, 130-139. doi: 10.1016/j.jconrel.2018.12.009 PMID: 30537486
  97. Vangala, V.; Nimmu, N.V.; Khalid, S.; Kuncha, M.; Sistla, R.; Banerjee, R.; Chaudhuri, A. Combating glioblastoma by codelivering the small-molecule inhibitor of STAT3 and STAT3siRNA with α5β1 integrin receptor-selective liposomes. Mol. Pharm., 2020, 17(6), 1859-1874. doi: 10.1021/acs.molpharmaceut.9b01271 PMID: 32343904
  98. Zhao, G.; Huang, Q.; Wang, F.; Zhang, X.; Hu, J.; Tan, Y.; Huang, N.; Wang, Z.; Wang, Z.; Cheng, Y. Targeted shRNA-loaded liposome complex combined with focused ultrasound for blood brain barrier disruption and suppressing glioma growth. Cancer Lett., 2018, 418, 147-158. doi: 10.1016/j.canlet.2018.01.035 PMID: 29339208
  99. Yuan, Z.; Zhao, L.; Zhang, Y.; Li, S.; Pan, B.; Hua, L.; Wang, Z.; Ye, C.; Lu, J.; Yu, R.; Liu, H. Inhibition of glioma growth by a GOLPH3 siRNA-loaded cationic liposomes. J. Neurooncol., 2018, 140(2), 249-260. doi: 10.1007/s11060-018-2966-6 PMID: 30105446
  100. Cheng, Y.; Zhao, L.; Li, Y.; Xu, T. Design of biocompatible dendrimers for cancer diagnosis and therapy: Current status and future per-spectives. Chem. Soc. Rev., 2011, 40(5), 2673-2703. doi: 10.1039/c0cs00097c PMID: 21286593
  101. Wang, Y.; Miao, Z.; Ren, G.; Xu, Y.; Cheng, Z. A novel affibody bioconjugate for dual-modality imaging of ovarian cancer. Chem. Commun., 2014, 50(85), 12832-12835. doi: 10.1039/C4CC03454F PMID: 24927395
  102. Zhou, Z.; Wu, X.; Kresak, A.; Griswold, M.; Lu, Z.R. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI. Biomaterials, 2013, 34(31), 7683-7693. doi: 10.1016/j.biomaterials.2013.06.057 PMID: 23863450
  103. Bai, C.Z.; Choi, S.; Nam, K.; An, S.; Park, J.S. Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glio-ma. Int. J. Pharm., 2013, 445(1-2), 79-87. doi: 10.1016/j.ijpharm.2013.01.057 PMID: 23384727
  104. Ma, M.; Cheng, Y.; Xu, Z.; Xu, P.; Qu, H.; Fang, Y.; Xu, T.; Wen, L. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carri-ers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug. Eur. J. Med. Chem., 2007, 42(1), 93-98. doi: 10.1016/j.ejmech.2006.07.015 PMID: 17095123
  105. Kaminskas, L.M.; McLeod, V.M.; Porter, C.J.H.; Boyd, B.J. Association of chemotherapeutic drugs with dendrimer nanocarriers: An as-sessment of the merits of covalent conjugation compared to noncovalent encapsulation. Mol. Pharm., 2012, 9(3), 355-373. doi: 10.1021/mp2005966 PMID: 22250750
  106. Li, Y.; He, H.; Jia, X.; Lu, W.L.; Lou, J.; Wei, Y. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Biomaterials, 2012, 33(15), 3899-3908. doi: 10.1016/j.biomaterials.2012.02.004 PMID: 22364698
  107. Han, S.; Zheng, H.; Lu, Y.; Sun, Y.; Huang, A.; Fei, W.; Shi, X.; Xu, X.; Li, J.; Li, F. A novel synergetic targeting strategy for glioma thera-py employing borneol combination with angiopep-2-modified, DOX-loaded PAMAM dendrimer. J. Drug Target., 2018, 26(1), 86-94. doi: 10.1080/1061186X.2017.1344849 PMID: 28635335
  108. Sharma, A.; Liaw, K.; Sharma, R.; Spriggs, T.; Appiani La Rosa, S.; Kannan, S.; Kannan, R.M. Dendrimer-mediated targeted delivery of rapamycin to tumor-associated macrophages improves systemic treatment of glioblastoma. Biomacromolecules, 2020, 21(12), 5148-5161. doi: 10.1021/acs.biomac.0c01270 PMID: 33112134
  109. Wang, K.; Zhang, X.; Liu, Y.; Liu, C.; Jiang, B.; Jiang, Y. Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of dox-orubicin-polymer conjugates. Biomaterials, 2014, 35(30), 8735-8747. doi: 10.1016/j.biomaterials.2014.06.042 PMID: 25023394
  110. Zhao, J.; Zhang, B.; Shen, S.; Chen, J.; Zhang, Q.; Jiang, X.; Pang, Z. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery. J. Colloid Interface Sci., 2015, 450, 396-403. doi: 10.1016/j.jcis.2015.03.019 PMID: 25863222
  111. Lu, Y.; Han, S.; Zheng, H.; Ma, R.; Ping, Y.; Zou, J.; Tang, H.; Zhang, Y.; Xu, X.; Li, F. A novel RGDyC/PEG co-modified PAMAM den-drimer-loaded arsenic trioxide of glioma targeting delivery system. Int. J. Nanomedicine, 2018, 13, 5937-5952. doi: 10.2147/IJN.S175418 PMID: 30323584
  112. Ban, J.; Li, S.; Zhan, Q.; Li, X.; Xing, H.; Chen, N.; Long, L.; Hou, X.; Zhao, J.; Yuan, X. PMPC modified PAMAM dendrimer enhances brain tumor-targeted drug delivery. Macromol. Biosci., 2021, 21(4), 2000392. doi: 10.1002/mabi.202000392 PMID: 33506646
  113. Sharma, A.K.; Gupta, L.; Sahu, H.; Qayum, A.; Singh, S.K.; Nakhate, K.T. Ajazuddin; Gupta, U. Chitosan engineered PAMAM den-drimers as nanoconstructs for the enhanced anti-cancer potential and improved in vivo brain pharmacokinetics of temozolomide. Pharm. Res., 2018, 35(1), 9. doi: 10.1007/s11095-017-2324-y PMID: 29294212
  114. Zolotarskaya, O.Y.; Xu, L.; Valerie, K.; Yang, H. Click synthesis of a polyamidoamine dendrimer-based camptothecin prodrug. RSC Ad-vanc., 2015, 5(72), 58600-58608. doi: 10.1039/C5RA07987J PMID: 26640689
  115. Wang, S.; Li, Y.; Fan, J.; Wang, Z.; Zeng, X.; Sun, Y.; Song, P.; Ju, D. The role of autophagy in the neurotoxicity of cationic PAMAM den-drimers. Biomaterials, 2014, 35(26), 7588-7597. doi: 10.1016/j.biomaterials.2014.05.029 PMID: 24906346
  116. Muniswamy, V.J.; Raval, N.; Gondaliya, P.; Tambe, V.; Kalia, K.; Tekade, R.K. 'Dendrimer-cationized-albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin. Int. J. Pharm., 2019, 555, 77-99. doi: 10.1016/j.ijpharm.2018.11.035 PMID: 30448308
  117. Lesniak, W.G.; Oskolkov, N.; Song, X.; Lal, B.; Yang, X.; Pomper, M.; Laterra, J.; Nimmagadda, S.; McMahon, M.T. Salicylic acid conju-gated dendrimers are a tunable, high performance CEST MRI nanoplatform. Nano Lett., 2016, 16(4), 2248-2253. doi: 10.1021/acs.nanolett.5b04517 PMID: 26910126
  118. Bae, Y.; Green, E.S.; Kim, G.Y.; Song, S.J.; Mun, J.Y.; Lee, S.; Park, J.I.; Park, J.; Ko, K.S.; Han, J.; Choi, J.S. Dipeptide-functionalized polyamidoamine dendrimer-mediated apoptin gene delivery facilitates apoptosis of human primary glioma cells. Int. J. Pharm., 2016, 515(1-2), 186-200. doi: 10.1016/j.ijpharm.2016.09.083 PMID: 27732896
  119. Jiang, Y.; Lv, L.; Shi, H.; Hua, Y.; Lv, W.; Wang, X.; Xin, H.; Xu, Q. PEGylated polyamidoamine dendrimer conjugated with tumor hom-ing peptide as a potential targeted delivery system for glioma. Colloids Surf. B Biointerfaces, 2016, 147, 242-249. doi: 10.1016/j.colsurfb.2016.08.002 PMID: 27518456
  120. Zhang, F.; Mastorakos, P.; Mishra, M.K.; Mangraviti, A.; Hwang, L.; Zhou, J.; Hanes, J.; Brem, H.; Olivi, A.; Tyler, B.; Kannan, R.M. Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers. Biomaterials, 2015, 52, 507-516. doi: 10.1016/j.biomaterials.2015.02.053 PMID: 25818456
  121. Garrigue, P.; Tang, J.; Ding, L.; Bouhlel, A.; Tintaru, A.; Laurini, E.; Huang, Y.; Lyu, Z.; Zhang, M.; Fernandez, S.; Balasse, L.; Lan, W.; Mas, E.; Marson, D.; Weng, Y.; Liu, X.; Giorgio, S.; Iovanna, J.; Pricl, S.; Guillet, B.; Peng, L. Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors. Proc. Natl. Acad. Sci. USA, 2018, 115(45), 11454-11459. doi: 10.1073/pnas.1812938115 PMID: 30348798
  122. An, J.M.; Ju, Y.; Kim, J.H.; Lee, H.; Jung, Y.; Kim, J.; Kim, Y.J.; Kim, J.; Kim, D. A metastasis suppressor Pt-dendrimer nanozyme for the alleviation of glioblastoma. J. Mater. Chem. B Mater. Biol. Med., 2021, 9(19), 4015-4023. doi: 10.1039/D1TB00425E PMID: 33954328
  123. Uram, Ł.; Markowicz, J.; Misiorek, M.; Filipowicz-Rachwał, A.; Wołowiec, S.; Wałajtys-Rode, E. Celecoxib substituted biotinylated poly(amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent. Eur. J. Pharm. Sci., 2020, 152, 105439. doi: 10.1016/j.ejps.2020.105439 PMID: 32615261
  124. Zhao, L.; Zhu, J.; Cheng, Y.; Xiong, Z.; Tang, Y.; Guo, L.; Shi, X.; Zhao, J. Chlorotoxin-conjugated multifunctional dendrimers labeled with radionuclide. 131I for single photon emission computed tomography Imaging and radiotherapy of gliomas. ACS Appl. Mater. Interfaces, 2015, 7(35), 19798-19808. doi: 10.1021/acsami.5b05836 PMID: 26291070
  125. Bae, Y.; Rhim, H.S.; Lee, S.; Ko, K.S.; Han, J.; Choi, J.S. Apoptin gene delivery by the functionalized polyamidoamine dendrimer deriva-tives induces cell death of U87-MG glioblastoma cells. J. Pharm. Sci., 2017, 106(6), 1618-1633. doi: 10.1016/j.xphs.2017.01.034 PMID: 28188727
  126. Sk, U.H.; Dixit, D.; Sen, E. Comparative study of microtubule inhibitors-Estramustine and natural podophyllotoxin conjugated PAMAM dendrimer on glioma cell proliferation. Eur. J. Med. Chem., 2013, 68, 47-57. doi: 10.1016/j.ejmech.2013.07.007 PMID: 23954240
  127. Cheng, Y.; Zhu, J.; Zhao, L.; Xiong, Z.; Tang, Y.; Liu, C.; Guo, L.; Qiao, W.; Shi, X.; Zhao, J. 131I-labeled multifunctional dendrimers modified with BmK CT for targeted SPECT imaging and radiotherapy of gliomas. Nanomedicine, 2016, 11(10), 1253-1266. doi: 10.2217/nnm-2016-0001 PMID: 26940668
  128. Sowińska, M.; Szeliga, M.; Morawiak, M.; Ziemińska, E.; Zabłocka, B.; Urbańczyk-Lipkowska, Z. Peptide dendrimers with non-symmetric bola structure exert long term effect on glioblastoma and neuroblastoma cell lines. Biomolecules, 2021, 11(3), 435. doi: 10.3390/biom11030435 PMID: 33804286
  129. Szwed, A.; Miłowska, K.; Michlewska, S.; Moreno, S.; Shcharbin, D.; Gomez-Ramirez, R.; de la Mata, F.J.; Majoral, J.P.; Bryszewska, M.; Gabryelak, T. Generation dependent effects and entrance to mitochondria of hybrid dendrimers on normal and cancer neuronal cells in vitro. Biomolecules, 2020, 10(3), 427. doi: 10.3390/biom10030427 PMID: 32182909
  130. Jin, Z.; Piao, L.; Sun, G.; Lv, C.; Jing, Y.; Jin, R. Dual functional nanoparticles efficiently across the blood-brain barrier to combat glio-blastoma via simultaneously inhibit the PI3K pathway and NKG2A axis. J. Drug Target., 2021, 29(3), 323-335. doi: 10.1080/1061186X.2020.1841214 PMID: 33108906
  131. Liu, X.; Li, G.; Su, Z.; Jiang, Z.; Chen, L.; Wang, J.; Yu, S.; Liu, Z. Poly(amido amine) is an ideal carrier of miR-7 for enhancing gene silencing effects on the EGFR pathway in U251 glioma cells. Oncol. Rep., 2013, 29(4), 1387-1394. doi: 10.3892/or.2013.2283 PMID: 23404538
  132. Kuang, Y.; An, S.; Guo, Y.; Huang, S.; Shao, K.; Liu, Y.; Li, J.; Ma, H.; Jiang, C. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting. Int. J. Pharm., 2013, 454(1), 11-20. doi: 10.1016/j.ijpharm.2013.07.019 PMID: 23867728
  133. Janiszewska, J.; Posadas, I.; Játiva, P.; Bugaj-Zarebska, M.; Urbanczyk-Lipkowska, Z.; Ceña, V. Second generation amphiphilic poly-lysine dendrons inhibit glioblastoma cell proliferation without toxicity for neurons or astrocytes. PLoS One, 2016, 11(11), e0165704. doi: 10.1371/journal.pone.0165704 PMID: 27832093
  134. Stenström, P.; Manzanares, D.; Zhang, Y.; Ceña, V.; Malkoch, M. Evaluation of amino-functional polyester dendrimers based on Bis-MPA as nonviral vectors for siRNA delivery. Molecules, 2018, 23(8), 2028. doi: 10.3390/molecules23082028 PMID: 30110914
  135. Qiu, J.; Kong, L.; Cao, X.; Li, A.; Wei, P.; Wang, L.; Mignani, S.; Caminade, A.M.; Majoral, J.P.; Shi, X. Enhanced delivery of therapeutic siRNA into glioblastoma cells using dendrimer-entrapped gold nanoparticles conjugated with β-Cyclodextrin. Nanomaterials, 2018, 8(3), 131. doi: 10.3390/nano8030131 PMID: 29495429
  136. Kong, L.; Wu, Y.; Alves, C.S.; Shi, X. Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles. Nanomedicine, 2016, 11(23), 3103-3115. doi: 10.2217/nnm-2016-0240 PMID: 27809656
  137. Ellert-Miklaszewska, A.; Ochocka, N.; Maleszewska, M.; Ding, L.; Laurini, E.; Jiang, Y.; Roura, A.J.; Giorgio, S.; Gielniewski, B.; Pricl, S.; Peng, L.; Kaminska, B. Efficient and innocuous delivery of small interfering RNA to microglia using an amphiphilic dendrimer nanovec-tor. Nanomedicine, 2019, 14(18), 2441-2459. doi: 10.2217/nnm-2019-0176 PMID: 31456476
  138. Sill, T.J.; von Recum, H.A. Electrospinning: Applications in drug delivery and tissue engineering. Biomaterials, 2008, 29(13), 1989-2006. doi: 10.1016/j.biomaterials.2008.01.011 PMID: 18281090
  139. Cui, W.; Zhou, Y.; Chang, J. Electrospun nanofibrous materials for tissue engineering and drug delivery. Sci. Technol. Adv. Mater., 2010, 11(1), 014108. doi: 10.1088/1468-6996/11/1/014108 PMID: 27877323
  140. Liang, D.; Hsiao, B.S.; Chu, B. Functional electrospun nanofibrous scaffolds for biomedical applications. Adv. Drug Deliv. Rev., 2007, 59(14), 1392-1412. doi: 10.1016/j.addr.2007.04.021 PMID: 17884240
  141. Son, Y.J.; Kim, W.J.; Yoo, H.S. Therapeutic applications of electrospun nanofibers for drug delivery systems. Arch. Pharm. Res., 2014, 37(1), 69-78. doi: 10.1007/s12272-013-0284-2 PMID: 24234913
  142. Norouzi, M.; Boroujeni, S.M.; Omidvarkordshouli, N.; Soleimani, M. Advances in skin regeneration: Application of electrospun scaffolds. Adv. Healthc. Mater., 2015, 4(8), 1114-1133. doi: 10.1002/adhm.201500001 PMID: 25721694
  143. Hu, X.; Liu, S.; Zhou, G.; Huang, Y.; Xie, Z.; Jing, X. Electrospinning of polymeric nanofibers for drug delivery applications. J. Control. Release, 2014, 185, 12-21. doi: 10.1016/j.jconrel.2014.04.018 PMID: 24768792
  144. Liu, S.; Zhou, G.; Liu, D.; Xie, Z.; Huang, Y.; Wang, X.; Wu, W.; Jing, X. Inhibition of orthotopic secondary hepatic carcinoma in mice by doxorubicin-loaded electrospun polylactide nanofibers. J. Mater. Chem. B Mater. Biol. Med., 2013, 1(1), 101-109. doi: 10.1039/C2TB00121G PMID: 32260617
  145. Bastiancich, C.; Danhier, P.; Préat, V.; Danhier, F. Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma. J. Control. Release, 2016, 243, 29-42. doi: 10.1016/j.jconrel.2016.09.034 PMID: 27693428
  146. Bhujbal, S.V.; de Vos, P.; Niclou, S.P. Drug and cell encapsulation: Alternative delivery options for the treatment of malignant brain tu-mors. Adv. Drug Deliv. Rev., 2014, 67-68, 142-153. doi: 10.1016/j.addr.2014.01.010 PMID: 24491927
  147. Lin, F.W.; Chen, P.Y.; Wei, K.C.; Huang, C.Y.; Wang, C.K.; Yang, H.W. Rapid in situ MRI traceable gel-forming dual-drug delivery for synergistic therapy of brain tumor. Theranostics, 2017, 7(9), 2524-2536. doi: 10.7150/thno.19856 PMID: 28744332
  148. Johnson, J.; Nowicki, M.O.; Lee, C.H.; Chiocca, E.A.; Viapiano, M.S.; Lawler, S.E.; Lannutti, J.J. Quantitative analysis of complex glioma cell migration on electrospun polycaprolactone using time-lapse microscopy. Tissue Eng. Part C Methods, 2009, 15(4), 531-540. doi: 10.1089/ten.tec.2008.0486 PMID: 19199562
  149. Agudelo-Garcia, P.A.; De Jesus, J.K.; Williams, S.P.; Nowicki, M.O.; Chiocca, E.A.; Liyanarachchi, S.; Li, P.K.; Lannutti, J.J.; Johnson, J.K.; Lawler, S.E.; Viapiano, M.S. Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling. Neoplasia, 2011, 13(9), 831-IN22. doi: 10.1593/neo.11612 PMID: 21969816
  150. Steffens, L.; Morás, A.M.; Arantes, P.R.; Masterson, K.; Cao, Z.; Nugent, M.; Moura, D.J. Electrospun PVA-dacarbazine nanofibers as a novel nano brain-implant for treatment of glioblastoma: In silico and in vitro characterization. Eur. J. Pharm. Sci., 2020, 143, 105183. doi: 10.1016/j.ejps.2019.105183 PMID: 31846696
  151. Graham-Gurysh, E.G.; Moore, K.M.; Schorzman, A.N.; Lee, T.; Zamboni, W.C.; Hingtgen, S.D.; Bachelder, E.M.; Ainslie, K.M. Tumor responsive and tunable polymeric platform for optimized delivery of paclitaxel to treat glioblastoma. ACS Appl. Mater. Interfaces, 2020, 12(17), 19345-19356. doi: 10.1021/acsami.0c04102 PMID: 32252517
  152. Graham-Gurysh, E.; Moore, K.M.; Satterlee, A.B.; Sheets, K.T.; Lin, F.C.; Bachelder, E.M.; Miller, C.R.; Hingtgen, S.D.; Ainslie, K.M. Sustained delivery of doxorubicin via acetalated dextran scaffold prevents glioblastoma recurrence after surgical resection. Mol. Pharm., 2018, 15(3), 1309-1318. doi: 10.1021/acs.molpharmaceut.7b01114 PMID: 29342360
  153. Lock, L.L.; Li, Y.; Mao, X.; Chen, H.; Staedtke, V.; Bai, R.; Ma, W.; Lin, R.; Li, Y.; Liu, G.; Cui, H. One-component supramolecular fila-ment hydrogels as theranostic label-free magnetic resonance imaging agents. ACS Nano, 2017, 11(1), 797-805. doi: 10.1021/acsnano.6b07196 PMID: 28075559
  154. Zhu, Y.; Jia, J.; Zhao, G.; Huang, X.; Wang, L.; Zhang, Y.; Zhang, L.; Konduru, N.; Xie, J.; Yu, R.; Liu, H. Multi-responsive nanofibers composite gel for local drug delivery to inhibit recurrence of glioma after operation. J. Nanobiotechnology, 2021, 19(1), 198. doi: 10.1186/s12951-021-00943-z PMID: 34217325
  155. Srikanth, M.; Das, S.; Berns, E.J.; Kim, J.; Stupp, S.I.; Kessler, J.A. Nanofiber-mediated inhibition of focal adhesion kinase sensitizes glioma stemlike cells to epidermal growth factor receptor inhibition. Neuro-oncol., 2013, 15(3), 319-329. doi: 10.1093/neuonc/nos316 PMID: 23328812
  156. Wang, B.; Li, H.; Yao, Q.; Zhang, Y.; Zhu, X.; Xia, T.; Wang, J.; Li, G.; Li, X.; Ni, S. Local in vitro delivery of rapamycin from electrospun PEO/PDLLA nanofibers for glioblastoma treatment. Biomed. Pharmacother., 2016, 83, 1345-1352. doi: 10.1016/j.biopha.2016.08.033 PMID: 27580454
  157. Xue, F.; Shen, R.; Chen, X. Analysis of gene profiles in glioma cells identifies potential genes, miRNAs, and target sites of migratory cells. Tumori, 2015, 101(5), 542-548. doi: 10.5301/tj.5000226 PMID: 25953448
  158. Norouzi, M.; Abdali, Z.; Liu, S.; Miller, D.W. Salinomycin-loaded nanofibers for glioblastoma therapy. Sci. Rep., 2018, 8(1), 9377. doi: 10.1038/s41598-018-27733-2 PMID: 29925966
  159. Karan, A.; Darder, M.; Kansakar, U.; Norcross, Z.; DeCoster, M. Integration of a copper-containing biohybrid (CuHARS) with cellulose for subsequent degradation and biomedical control. Int. J. Environ. Res. Public Health, 2018, 15(5), 844. doi: 10.3390/ijerph15050844 PMID: 29693569

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bentham Science Publishers, 2023